Posted in | News | Materials Testing | Business

Malvern Now Handling Particle Sizing Business Directly in Japan

Malvern Panalytical has marked the extension of its direct operations in Japan with a celebration held on 1 October 2010 at the offices of Malvern Panalytical Japan in Kobe. Malvern Panalytical Japan was established in February 2003 to manage Malvern Panalytical's process business in the region. The newly expanded organisation is now set to deliver direct sales, technical and applications support across the entire range of the company's particle characterization systems.

This follows the conclusion of an agreement with Sysmex Corporation, who previously distributed Malvern Panalytical's laboratory-based particle characterization systems in Japan, to transfer responsibility directly to Malvern Panalytical. The two companies have also signed a new exclusive distribution agreement for the Sysmex FPIA particle characterization instrument, which will make Malvern Panalytical the worldwide distributor including Japan.

Guests at the celebratory lunch were addressed by both Paul Walker, Managing Director of Malvern Panalytical, and Hisashi Ietsugu, President and CEO of Sysmex Corporation, as well as Jim Fatkin, Malvern Panalytical's Regional Manager for Asia.

Paul Walker thanked and paid tribute to the Sysmex teams, with whom Malvern Panalytical has worked since 1998 and looked forward to building on the sound base of business that Sysmex has developed for Malvern Panalytical's particle characterization systems in Japan:

"With the continued growth and diversification of the Malvern Panalytical product range, now is the right time for us to extend our direct operation in Japan and to manage our particle characterization business through a single organization, as we do elsewhere," said Mr Walker. "I am delighted that we have also concluded a new distribution agreement for the Sysmex FPIA systems worldwide and that Malvern Panalytical and Sysmex will continue to collaborate in developing particle characterization systems for the bioscience community.."

Hisashi Ietsugu, President and CEO of Sysmex Corporation said: "The transfer of the Malvern Panalytical and Sysmex industrial particle characterization business to Malvern Panalytical Japan is a logical step in the development of our longstanding and successful relationship, in order to exploit synergies between products and markets. At the same time we are happy to have concluded a distribution agreement with Malvern Panalytical for the Sysmex FPIA instrument, both inside and outside Japan, which we expect will enable us to further build on our success. While we will continue to collaborate in the industrial particle characterization area, we hope that opportunities will arise for the joint development of exciting new products in the bioscience field."

For further information about Malvern Panalytical Japan please contact:

Malvern Panalytical Japan,
South Bldg 658 Kobe International Business Center,
5-5-2 Minatojimaminami-machi Chuo-ku, Kobe-shi
Hyogo Prefecture 650-0047, Japan
Tel: +81 (0) 78 306 3806 Fax: +81 (0) 78 306 3807

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Malvern Panalytical. (2021, March 09). Malvern Now Handling Particle Sizing Business Directly in Japan. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=24745.

  • MLA

    Malvern Panalytical. "Malvern Now Handling Particle Sizing Business Directly in Japan". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=24745>.

  • Chicago

    Malvern Panalytical. "Malvern Now Handling Particle Sizing Business Directly in Japan". AZoM. https://www.azom.com/news.aspx?newsID=24745. (accessed November 21, 2024).

  • Harvard

    Malvern Panalytical. 2021. Malvern Now Handling Particle Sizing Business Directly in Japan. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=24745.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.